Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $400.0000 (-5.88%) ($375.0000 - $425.0000) on Sun. Jan. 4, 2009. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 16.84% (three month average) | | RSI | 51 | | Latest Price | $400.0000(-5.88%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -2.8% a day on average for past five trading days. | | Weekly Trend | CAPR declines -6.9% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting CAPR price | CAPR will decline at least -8.42% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -8.42% (StdDev 16.84%) | | Hourly BBV | 0 () | | Intraday Trend | -5.9% | | | | | |
|
| Resistance Level | $423.22 | | 5 Day Moving Average | $439.44(-8.98%) | | 10 Day Moving Average | $456.43(-12.36%) | | 20 Day Moving Average | $423.22(-5.49%) | | To recent high | -78.7% | | To recent low | 90.5% | | Market Cap | $N/A | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |